Sam Srivastava

Sam Srivastava is the CEO of WCG. He is a transformative health care executive with a proven track record of driving growth and innovation in health care delivery. Sam has a passion to deliver better healthcare and is committed to leading with compassion. Prior to WCG, he served as the CEO of NeueHealth, and COO for Bright Health leading strategy, development, integration, and operations.

Before joining Bright Health, Sam served as CEO at Magellan Healthcare, a leading behavioral, specialty and pharmacy management company serving 50M customers worldwide. During his tenure, the company diversified, doubled in size, launched the nation’s first health plan for the seriously mentally ill and developed digital therapeutics and advanced illness care programs.

Prior to Magellan, Sam worked at Cigna where he was president of the national employer and Medicare businesses. He also led US strategy and business development, that included the strategic acquisition of HealthSpring and launch of Cigna Ventures. Sam has also held executive positions leading the Commercial, Medicare, and Medicaid businesses at UnitedHealth Group. He has also served as a management consultant in the US and Europe, developing risk-based integrated delivery systems for providers, insurers, and governments.

Sam serves as the advisory council chairman of the Yale School of Public Health, as well as board director for the Recovery Centers of America. He is a frequent national speaker and has testified to Congress regarding the opioid crisis aiding in the passage of the bipartisan SUPPORT act. Sam holds a Bachelor of Arts in medical science and humanities from Kent State University and completed graduate work at Yale University in health care management.